BIODESIX INC — Director's Dealing 2021

Apr 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-04-01

Reporting Person: Cowie Robin Harper (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-01	Common Stock	M	2526	$2.62	Acquired	3526	Direct
2021-04-01	Common Stock	M	8172	$0.84	Acquired	11698	Direct
2021-04-01	Common Stock	M	14326	$0.42	Acquired	26024	Direct
2021-04-01	Common Stock	M	13689	$0.42	Acquired	39713	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Stock Options (Right to buy)	$2.62	M	2526	Disposed	2021-04-21	Common Stock (2526)	Direct
2021-04-01	Stock Options (Right to buy)	$0.84	M	8172	Disposed	2026-04-06	Common Stock (8172)	Direct
2021-04-01	Stock Options (Right to buy)	$0.42	M	14326	Disposed	2027-05-15	Common Stock (14326)	Direct
2021-04-01	Stock Options (Right to buy)	$0.42	M	13689	Disposed	2028-04-03	Common Stock (13689)	Direct

Footnotes

F1: This option vested 40% on March 28, 2013, and the remaining 60% in 36 successive, equal monthly installments measured from March 28, 2013.

F2: This option vests in 60 successive, equal monthly installments measured from January 1, 2017.

F3: This option vests in 60 successive, equal monthly installments measured from January 1, 2018.